We are live on ! Find out more
LPC

Lion Point Capital Portfolio holdings

AUM $20.9M
1-Year Est. Return 195.52%
This Fund
S&P 500
This Quarter Est. Return
-4.5%
1 Year Est. Return
+195.52%
3 Year Est. Return
+318.83%
5 Year Est. Return
+369%
10 Year Est. Return
+2,361.28%
AUM
$16.7M
AUM Growth
-$2.59M
Cap. Flow
-$492K
Cap. Flow %
-2.94%
Top 10 Hldgs %
54.62%
Holding
39
New
–
Increased
3
Reduced
–
Closed
4

Top Buys

Rank Stock Value
1
HUMA icon
Humacyte
HUMA
+$156K
2
CMPS
Compass Pathways
CMPS
+$148K
3
MIST icon
Milestone Pharmaceuticals
MIST
+$114K

Top Sells

Rank Stock Value
1
DAWN
Day One Biopharmaceuticals
DAWN
+$391K
2
VTYX
Ventyx Biosciences
VTYX
+$375K
3
NERV icon
Minerva Neurosciences
NERV
+$141K
4
MRSN
Mersana Therapeutics
MRSN
+$2.89K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCRB icon
26
Seres Therapeutics
MCRB
$49.7M
$280K 1.67%
31,570
– –
JANX icon
27
Janux Therapeutics
JANX
$1.15B
$264K 1.58%
19,000
– –
QURE icon
28
uniQure
QURE
$3.44B
$240K 1.44%
14,700
– –
RGNX icon
29
Regenxbio
RGNX
$619M
$223K 1.33%
26,600
– –
AZTA icon
30
Azenta
AZTA
$1.47B
$205K 1.23%
9,700
– –
INVA icon
31
Innoviva
INVA
$1.51B
$191K 1.14%
8,200
– –
GHRS icon
32
GH Research
GHRS
$1.97B
$143K 0.86%
10,200
– –
ARQT icon
33
Arcutis Biotherapeutics
ARQT
$3.13B
$124K 0.74%
5,250
– –
IPHA
34
Innate Pharma
IPHA
$249M
$104K 0.62%
81,151
– –
SPRB
35
Spruce Biosciences
SPRB
$182M
$65.3K 0.39%
1,000
– –
DAWN
36
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-42,000
Closed -$391K
MRSN
37
DELISTED
Mersana Therapeutics
MRSN
– –
-100
Closed -$2.89K
NERV icon
38
Minerva Neurosciences
NERV
$245M
– –
-35,000
Closed -$141K
VTYX
39
DELISTED
Ventyx Biosciences
VTYX
– –
-41,500
Closed -$375K
1
2

Similar funds

SCM
Stadium Capital Management New Canaan, Connecticut $21M AUM 6.45% 1-Year Est. Return
MPW
MGO Private Wealth Irvine, California $20.7M AUM 18.57% 1-Year Est. Return
FS
Financially Speaking Greenwood Village, Colorado $20.6M AUM 16.79% 1-Year Est. Return
VAM
Vazirani Asset Management New York $20.3M AUM 79.33% 1-Year Est. Return
SPC
Stone Point Capital Greenwich, Connecticut $21.7M AUM 48.55% 1-Year Est. Return
SCM
Semanteon Capital Management Newton, Massachusetts $22.2M AUM 53.69% 1-Year Est. Return
HIIL
HS Investments III Ltd St. Peter Port $22.3M AUM
PMAM
Penn Mutual Asset Management Conshohocken, Pennsylvania $19.5M AUM 3.07% 1-Year Est. Return

Lion Point Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Lion Point Capital held 39 positions worth $16.7M, down 13% from $19.3M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Lion Point Capital's Q1 2026 filing shows 3 increased and 4 closed positions. The largest sale was Day One Biopharmaceuticals, an estimated $391K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Lion Point Capital added most to Humacyte in Q1 2026, an estimated $156K increase.
  • Lion Point Capital fully exited Day One Biopharmaceuticals in Q1 2026, selling an estimated $391K.
  • Lion Point Capital's ten largest holdings make up 55% of its $16.7M portfolio in Q1 2026.
  • Lion Point Capital opened 0 new positions and closed 4 in Q1 2026.
  • Lion Point Capital's portfolio value fell 13% quarter-over-quarter to $16.7M.

Based on Lion Point Capital's 13F filing for Q1 2026, filed 15 May 2026.